Fig. 1 · Structure
Documents & Downloads
Lithium chloride hydrate
Neuroprotective Agent
Lithium chloride hydrate primarily acts as a neuroprotective agent through the inhibition of glycogen synthase kinase 3 beta (GSK3β). This compound demonstrates antidepressant properties and promotes neurogenesis, offering potential therapeutic benefits for cognitive dysfunction, acute mania, and depression. Additionally, Lithium chloride hydrate is valuable for research focused on viral infections and Alzheimer's disease, making it relevant for studies exploring neuroprotective mechanisms and immunomodulatory effects.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 85144-11-2 |
| Applications | Neuroprotective Agent |
| Formula | LiCl · xH2O |
| Molecular Weight | 42.39 (anhydrous basis) |
| Synonyms | hydrate/monohydrateortrihydrate |
| SMILES | [Li]Cl.O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.